A dual mechanism of action for skeletal muscle FAT/CD36 during exercise

Exercise and Sport Sciences Reviews

Volumn 40, Issue 4, 2012, Pages 211-217

  Smith, Brennan K ^a   Bonen, Arend ^a   Holloway, Graham P ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

carbohydrate sparing; exercise; FAT CD36; fatty acid oxidation; mitochondria; sarcolemma

Indexed keywords

CD36 ANTIGEN;

ANIMAL; ARTICLE; EXERCISE; HUMAN; LIPID METABOLISM; METABOLISM; MITOCHONDRIAL MEMBRANE; OXIDATION REDUCTION REACTION; PHYSIOLOGY; SARCOLEMMA; SKELETAL MUSCLE; UPREGULATION;

ANIMALS; ANTIGENS, CD36; EXERCISE; HUMANS; LIPID METABOLISM; MITOCHONDRIAL MEMBRANES; MUSCLE, SKELETAL; OXIDATION-REDUCTION; SARCOLEMMA; UP-REGULATION;

EID: 84866941177     PISSN: 00916331     EISSN: None     Source Type: Journal    
DOI: 10.1097/JES.0b013e31825eb263     Document Type: Article

References (40)

1. Abbott MJ, Edelman AM, Turcotte LP. CaMKK is an upstream signal of AMP-activated protein kinase in regulation of substrate metabolism in contracting skeletal muscle. Am. J. Physiol Regul. Integr. Comp Physiol. 2009; 297:R1724-32.
2. Benton CR, Nickerson JG, Lally J, et al. Modest PGC-1alpha overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria. J. Biol. Chem. 2008; 283:4228-40.
3. Bonen A, Han XX, Habets DD, Febbraio M, Glatz JF, Luiken JJ. A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism. Am. J. Physiol Endocrinol. Metab. 2007; 292:E1740-9.
4. Bonen A, Luiken JJ, Arumugam Y, Glatz JF, Tandon NN. Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J. Biol. Chem. 2000; 275:14501-8.
5. Bonen A, Luiken JJ, Liu S, et al. Palmitate transport and fatty acid transporters in red and white muscles. Am. J. Physiol. 1998; 275:E471-8.
6. Bradley NS, Snook LA, Jain SS, Heigenhauser GJ, Bonen A, Spriet LL. Acute endurance exercise increases plasma membrane fatty acid transport proteins in rat and human skeletal muscle. Am. J. Physiol Endocrinol. Metab. 2012; 302:E183-9.
7. Campbell SE, Tandon NN, Woldegiorgis G, Luiken JJ, Glatz JF, Bonen A. A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria. J. Biol. Chem. 2004; 279:36235-41.
8. Chabowski A, Coort SL, Calles-Escandon J, et al. The subcellular compartmentation of fatty acid transporters is regulated differently by insulin and by AICAR. FEBS Lett. 2005; 579:2428-32.
9. Clarke DC, Miskovic D, Han XX, et al. Overexpression of membraneassociated fatty acid binding protein (FABPpm) in vivo increases fatty acid sarcolemmal transport and metabolism. Physiol. Genomics. 2004; 17:31-7.
10. Distler AM, Kerner J, Peterman SM, Hoppel CL. A targeted proteomic approach for the analysis of rat liver mitochondrial outer membrane proteins with extensive sequence coverage. Anal. Biochem. 2006; 356:18-29.
11. Glatz JF, Luiken JJ, Bonen A. Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol. Rev. 2010; 90:367-417.
12. Hickson RC, Rennie MJ, Conlee RK, Winder WW, Holloszy JO. Effects of increased plasma fatty acids on glycogen utilization and endurance. J. Appl. Physiol. 1977; 43:829-33.
13. Holloway GP, Bezaire V, Heigenhauser GJ, et al. Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise. J. Physiol. 2006; 571:201-10.
14. Holloway GP, Jain SS, Bezaire VS, et al. FAT/CD36 null mice reveal that mitochondrial FAT/CD36 is required to up-regulate mitochondrial fatty acid oxidation in contracting muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009; 297:R960-7.
15. Holloway GP, Lally J, Nickerson JG, et al. Fatty acid binding protein facilitates sarcolemmal fatty acid transport but not mitochondrial oxidation in rat and human skeletal muscle. J. Physiol. 2007; 582: 393-405.
16. Jain SS, Chabowski A, Snook LA, et al. Additive effects of insulin and muscle contraction on fatty acid transport and fatty acid transporters, FAT/CD36, FABPpm, FATP1, 4 and 6. FEBS Lett. 2009; 583: 2294-300.
17. Jeppesen J, Albers PH, Rose AJ, et al. Contraction-induced skeletal muscle FAT/CD36 trafficking and FA uptake is AMPK independent. J. Lipid Res. 2011; 52:699-711.
18. Kerner J, Hoppel C. Fatty acid import into mitochondria. Biochim. Biophys. Acta. 2000; 1486:1-17.
19. King KL, Stanley WC, Rosca M, Kerner J, Hoppel CL, Febbraio M. Fatty acid oxidation in cardiac and skeletal muscle mitochondria is unaffected by deletion of CD36. Arch. Biochem. Biophys. 2007; 467:234-8.
20. Kolodziej MP, Zammit VA. Re-evaluation of the interaction of malonyl- CoA with the rat liver mitochondrial carnitine palmitoyltransferase system by using purified outer membranes. Biochem. J. 1990; 267:85-90.
21. Koonen DP, Benton CR, Arumugam Y, et al. Different mechanisms can alter fatty acid transport when muscle contractile activity is chronically altered. Am. J. Physiol Endocrinol. Metab. 2004; 286:E1042-9.
22. Lally JS, Jain SS, Han XX, et al. Caffeine-stimulated fatty acid oxidation is blunted in CD36 null mice. Acta Physiol. (Oxf). 2011; in press.
23. Luiken JJ, Coort SL, Koonen DP, Bonen A, Glatz JF. Signaling components involved in contraction-inducible substrate uptake into cardiac myocytes. Proc. Nutr. Soc. 2004; 63:251-8.
24. Luiken JJ, Coort SL, Willems J, et al. Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes. 2003; 52: 1627-34.
25. Nickerson JG, Alkhateeb H, Benton CR, et al. Greater transport efficiencies of the membrane fatty acid transporters FAT/CD36 and FATP4 compared with FABPpm and FATP1 and differential effects on fatty acid esterification and oxidation in rat skeletal muscle. J. Biol. Chem. 2009; 284:16522-30.
26. O'Neill HM, Maarbjerg SJ, Crane JD, et al. AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise. Proc. Natl. Acad. Sci. U. S. A. 2011; 108:16092-7.
27. Odland LM, Heigenhauser GJ, Lopaschuk GD, Spriet LL. Human skeletal muscle malonyl-CoA at rest and during prolonged submaximal exercise. Am. J. Physiol. 1996; 270:E541-4.
28. Perry CG, Lally J, Holloway GP, Heigenhauser GJ, Bonen A, Spriet LL. Repeated transient mRNA bursts precede increases in transcriptional and mitochondrial proteins during training in human skeletal muscle. J. Physiol. 2010; 588:4795-810.
29. Raney MA, Yee AJ, Todd MK, Turcotte LP. AMPK activation is not critical in the regulation of muscle FA uptake and oxidation during lowintensity muscle contraction. Am. J. Physiol Endocrinol. Metab. 2005; 288: E592-8.
30. Roepstorff C, Halberg N, Hillig T, et al. Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise. Am. J. Physiol Endocrinol. Metab. 2005; 288:E133-42.
31. Schenk S, Horowitz JF. Coimmunoprecipitation of FAT/CD36 and CPT I in skeletal muscle increases proportionally with fat oxidation after endurance exercise training. Am. J. Physiol Endocrinol. Metab. 2006; 291: E254-60.
32. Schwenk RW, Holloway GP, Luiken JJ, Bonen A, Glatz JF. Fatty acid transport across the cell membrane: regulation by fatty acid transporters. Prostaglandins Leukot. Essent. Fatty Acids. 2010; 82:149-54.
33. Sebastian D, Guitart M, Garcia-Martinez C, et al. Novel role of FATP1 in mitochondrial fatty acid oxidation in skeletal muscle cells. J. Lipid Res. 2009; 50:1789-99.
34. Smith BK, Jain SS, Rimbaud S, et al. FAT/CD36 is located on the outer mitochondrial membrane, upstream of long-chain acyl-CoA synthetase, and regulates palmitate oxidation. Biochem. J. 2011; 437:125-34.
35. Talanian JL, Holloway GP, Snook LA, Heigenhauser GJ, Bonen A, Spriet LL. Exercise training increases sarcolemmal and mitochondrial fatty acid transport proteins in human skeletal muscle. Am. J. Physiol Endocrinol. Metab. 2010; 299:E180-8.
36. Thomson DM, Brown JD, Fillmore N, et al. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle. Am. J. Physiol Endocrinol. Metab. 2007; 293:E1572-9.
37. Tunstall RJ, Mehan KA, Wadley GD, et al. Exercise training increases lipid metabolism gene expression in human skeletal muscle. Am. J. Physiol Endocrinol. Metab. 2002; 283:E66-72.
38. Turcotte LP, Kiens B, Richter EA. Saturation kinetics of palmitate uptake in perfused skeletal muscle. FEBS Lett. 1991; 279:327-9.
39. Turcotte LP, Raney MA, Todd MK. ERK1/2 inhibition prevents contraction-induced increase in plasma membrane FAT/CD36 content and FA uptake in rodent muscle. Acta Physiol Scand. 2005; 184:131-9.
40. Wall BT, Stephens FB, Constantin-Teodosiu D, Marimuthu K, Macdonald IA, Greenhaff PL. Chronic oral ingestion of L-carnitine and carbohydrate increases muscle carnitine content and alters muscle fuel metabolism during exercise in humans. J. Physiol. 2011; 589: 963-73.